@article{c7f728df22884e6b8f2f2cb41a10a92e,
title = "Renal Cell Carcinoma Pseudoprogression with Clinical Deterioration: To Hospice and Back",
keywords = "Checkpoint inhibitors, Hyperprogression, Immune-related adverse events, Immunotherapy, Infection, SBRT",
author = "Roy Elias and Payal Kapur and Ivan Pedrosa and James Brugarolas",
note = "Funding Information: J.P., P.K., and I.P. are supported by the National Institute of Health (grant P50CA196516). Funding Information: J.P., P.K., and I.P. are supported by the National Institute of Health (grant P50CA196516 ).",
year = "2018",
month = dec,
doi = "10.1016/j.clgc.2018.07.015",
language = "English (US)",
volume = "16",
pages = "485--488",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier",
number = "6",
}